244k custom gene expression microarray platform (Agilent technologies)
Structured Review

244k Custom Gene Expression Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/244k custom gene expression microarray platform/product/Agilent technologies
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis"
Article Title: WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis
Journal: OncoTargets and therapy
doi: 10.2147/OTT.S97025
Figure Legend Snippet: Outlier gene analysis from TCGA dataset and three independent CRC microarray cohorts. Notes: Top 20 genes ranked in 90th and 75th outlier genes from TCGA dataset ( A ); No WISP3 positive cases defined by 90th and 75th cutoff was observed in normal colorectal tissues ( B ); WISP3 demonstrated significant outlier expression model in three independent CRC cohorts, Vilar Colorectal 2 ( C ); Vilar Colorectal ( D ); Smith Colorectal ( E ). Abbreviations: COPA, cancer outlier profile analysis; CRC, colorectal cancer; TCGA, The Cancer Genome Atlas; WISP3, WNT1-inducible-signaling pathway protein 3.
Techniques Used: Microarray, Expressing